S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran — and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran — and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran — and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran — and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
NASDAQ:HSGX

Histogenics (HSGX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.60
$1.76
50-Day Range
$0.16
$3.07
52-Week Range
$0.08
$1.43
Volume
8.06 million shs
Average Volume
9.06 million shs
Market Capitalization
$161.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HSGX stock logo

About Histogenics Stock (NASDAQ:HSGX)

Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.

HSGX Stock News Headlines

The Next Bitcoin Millionaires
100,000 people became millionaires during Bitcoin’s last bull market. If you missed out… You have a second chance.
Buy Alert
Imagine knowing, ahead of time, what the best investments of the year would be… Well, investors no longer need to imagine, guess, or throw darts. See, we’ve uncovered what looks to be a list of THE 10 best opportunities for 2024.
CN.ORTH: New Blood on The Board - Yahoo Finance
See More Headlines
Receive HSGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogenics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/09/2018
Today
4/14/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical Appliances & Supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:HSGX
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

Net Income
$-8,640,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.01) per share

Miscellaneous

Free Float
N/A
Market Cap
$161.76 million
Optionable
Not Optionable
Beta
3.10
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Adam D. Gridley (Age 47)
    Interim Pres, CEO Treasurer, Sec., Consultant & Director
  • Mr. Jonathan I. Lieber (Age 49)
    Interim Chief Financial Officer
  • Mr. Stephen R. Kennedy (Age 62)
    Consultant

HSGX Stock Analysis - Frequently Asked Questions

How were Histogenics' earnings last quarter?

Histogenics Corp (NASDAQ:HSGX) posted its quarterly earnings data on Thursday, August, 9th. The biotechnology company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.23) by $0.10.

What other stocks do shareholders of Histogenics own?
When did Histogenics IPO?

Histogenics (HSGX) raised $60 million in an initial public offering on Wednesday, December 3rd 2014. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Cowen and Company, Needham & Company and Canaccord Genuity served as the underwriters for the IPO and BTIG was co-manager.

This page (NASDAQ:HSGX) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners